Randomized, multicenter, active-controlled open-label study of NPC-25, zinc histidine hydrate, (non-inferiority to NOBELZIN™, zinc acetate dihydrate) for patients with hypozincemia

Randomized, multicenter, active-controlled open-label study of NPC-25, zinc histidine hydrate, (non-inferiority to NOBELZIN™, zinc acetate dihydrate) for patients with hypozincemia

This study evaluated the efficacy and safety of NPC-25, zinc histidine hydrate, in patients with hypozincemia. This randomized multicenter active-controlled open-label trial aimed to verify the non-inferiority of NPC-25 to NOBELZIN™, zinc acetate dihydrate. Participants whose serum zinc concentratio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of trace elements in medicine and biology 2025-02, Vol.87, p.127558, Article 127558
Hauptverfasser: Asaoka, Daisuke, Ishihara, Tomomi, Ezoe, Sachiko, Hamada, Izumi, Kitamura, Motohiro, Uchino, Kuniyasu, Arai, Kunio, Kanno, Yoshihiko, Kodama, Hiroko
Format: Artikel
Sprache:eng
Schlagworte:
Hypozincemia
Non-inferiority clinical trial
Zinc
Zinc-histidine complex
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This study evaluated the efficacy and safety of NPC-25, zinc histidine hydrate, in patients with hypozincemia. This randomized multicenter active-controlled open-label trial aimed to verify the non-inferiority of NPC-25 to NOBELZIN™, zinc acetate dihydrate. Participants whose serum zinc concentrations were
ISSN:0946-672X
1878-3252
1878-3252
DOI:10.1016/j.jtemb.2024.127558